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Summary
Objectives: This analysis estimated alcohol-attributable burden 
of disease for Switzerland.
Methods: Exposure distributions were taken from the 2002 
Swiss Health Survey and adjusted for per capita consumption. 
Risk relations were taken from meta-analyses. Mortality and 
burden of disease data were taken from the World Health Or-
ganization. 
Results: Overall consumption and alcohol-attributable mortal-
ity and burden of disease in Switzerland were high compared 
to European and global averages, especially among women. 
Overall in Switzerland in 2002, 2016 deaths (5.2 % of all deaths 
in men, 1.4 % in women), 28,939 years of life lost (men: 10.5 %, 
women: 4.9 %) and 70,256 disability adjusted life years (men: 
12.9 %, women: 4.2 %) were attributable to alcohol. These 
numbers are net numbers already incorporating the cardio-
protective and other benefi cial effects of alcohol. 
Conclusions: Limitations of the approach used are discussed. 
In addition, questions of causality and confounding are ad-
dressed.
Key words. Alcohol – Switzerland – Burden of disease – Mortality 
– Years of life lost – Disability adjusted life years (DALYs).
Alcohol is one of the most important risk factors worldwide 
for global burden of disease, with 4.0 % of the total burden 
attributable to this exposure ((Ezzati et al. 2002; Ezzati et al. 
2004; WHO, 2002; Lopez et al. 2006); for details on alco-
hol see (Rehm et al. 2003a; Rehm et al. 2003b; Rehm et al. 
2004)). In Europe especially, alcohol consumption and attrib-
utable burden of disease is high compared to global averages. 
In 2002, adult per capita alcohol consumption was estimated 
to be 11.9 litres (l) pure alcohol in Europe, almost twice the 
global average of 6.2 l (Rehm et al. 2006a). In terms of bur-
den of disease, Europe was found to have alcohol-attributable 
deaths, years of life lost (YLL) and disability adjusted life 
years (DALYs) that were double or triple those estimated glo-
bally (Rehm et al. 2006a). Within Europe there are regional 
differences as well: patterns of drinking and burden of disease 
have a very defi nite West to East gradient, with less detrimen-
tal patterns of consumption (such as drinking in moderation 
and with meals) in Western Europe and more harmful patterns 
(such as heavy episodic drinking) in Central and Eastern Eu-
rope (Popova et al. 2007; Rehm et al. 2007a). As a result, an 
increasing gradient of alcohol-attributable disease was also 
seen for 2002, with rates of deaths, YLLs and DALYs increas-
ing from West to East (Rehm et al. 2006a; Rehm et al. 2007a). 
In addition, there are regional patterns that are sex-specifi c 
(Makela et al. 2006).
In addition to regional trends in alcohol consumption and 
attributable disease, Europe is heterogeneous at the country 
level with respect to alcohol consumption and attributable 
harm. Likewise, the type of alcohol most widely consumed 
varies from country to country, with a particular increase in 
beer drinking and a corresponding decrease in wine and spir-
its consumption in the past decades (WHO Global Alcohol 
Database: http://www.who.int/globalatlas/default.asp ). Thus, 
to develop policy recommendations, the World Health Organ-
ization (WHO) stressed the importance of efforts to monitor 
alcohol consumption at the country level and recommend cor-
responding alcohol policy that serve individual country needs 
(World Health Assembly 2005). 
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Table 1 Relative risks for alcohol-attributable diseases and injuries by consumption stratum (reference group is “current abstainers”)
Disease condition ICD-10 GBD code Drinking 
category I
RR
Drinking 
category II
RR
Drinking 
category III
RR
Sources and comments
Conditions arising during the 
perinatal period: Low birthweight
P05-P07 U050 M/W 1.00 M/W 1.40 M/W 1.40 (Gutjahr et al., 2001; 
Rehm et al., 2004)
Mouth and oropharynx cancers C00-C14 U061 M/W 1.45 M/W 1.85 M/W 5.39 (Gutjahr et al., 2001)
Esophageal cancer C15 U062 M/W 1.80 M/W 2.38 M/W 4.36 (Gutjahr et al., 2001)
Colon and rectal cancers C18-C21 U064 M/W 1.00 M 1.16
W 1.01
M 1.41
W 1.41
(Cho et al., 2004)
Liver cancer C22 U065 M/W 1.45 M/W 3.03 M/W 3.60 (Gutjahr et al., 2001)
Breast cancer C50 U069 < 45 yrs
W 1.15
45+ yrs
W 1.14
< 45 yrs
W 1.41
45+ yrs
W 1.38
< 45 yrs
W 1.46
45+ yrs
W 1.62
(Ridolfo & Stevenson, 
2001)
Other neoplasms D00-D48 U078 M/W 1.10 M/W 1.30 M/W 1.70 (Rehm et al., 2004)
Diabetes mellitus (A regions) E10-E14 U079 M 0.99
W 0.92
M 0.57
W 0.87
M 0.73
W 1.13
(Gutjahr et al., 2001)
Diabetes mellitus (Non-A regions) E10-E14 U079 M/W 1.00 M/W 1.0 M 1.00
W 1.13
(Gutjahr et al., 2001)
Alcohol use disorders F10 U086 – – – AF 100 %
Unipolar depressive disorders a F32-F33 U082 (Rehm et al., 2004)
Epilepsy G40, G41 U085 M 1.23
W 1.34
M 7.52
W 7.22
M 6.83
W 7.52
(Gutjahr et al., 2001)
Hypertensive heart disease I10-I14 U106 M 1.33
W 1.15
M 2.04
W 1.53
M 2.91
W 2.19
(Corrao et al., 1999)
Ischaemic heart diseasea I20-I25 U107 M/W 0.82 M/W 0.83 M 1.00
W 1.12
(Corrao et al., 2000); 
(Rehm et al., 2004)
Haemorrhagic stroke (A regions) I60-I62 U108 M 1.12
W 0.74
M 1.40
W 1.04
M 1.54
W 1.94
(Reynolds et al., 2003)
Haemorrhagic stroke (Non-A regions) I60-I62 U108 M 1.12
W 1.00
M 1.40
W 1.04
M 1.54
W 1.94
(Reynolds et al., 2003)
Ischaemic stroke (A regions) I63 U108 M 0.94
W 0.66
M 1.13
W 0.84
M 1.19
W 1.53
(Reynolds et al., 2003)
Ischaemic stroke (Non-A regions) I63 U108 M/W 1.00 M 1.13
W 1.00
M 1.19
W 1.53
(Reynolds et al., 2003)
Cirrhosis of the liver a K74 U117 M/W 1.26 M/W 9.54 M/W 13.0 (Rehm et al., 2004) 
Road traffi c accidents a b   U150
For all injury categories (shaded areas), 
the approach assuming that consumption 
strata specifi c RRs are generalisable across 
countries was only used as a sensitivity 
analysis. The main analyses used region-
specifi c alcohol-attributable fractions, based 
on both the level of consumption and 
drinking pattern (for derivation see Rehm 
et al., 2004).
(Rehm et al., 2004)
Poisonings a X40-X49 U151 (Rehm et al., 2004)
Falls a W00-W19 U152 (Rehm et al., 2004)
Drownings a W65-W74 U154 (Rehm et al., 2004)
Other unintentional injuries a Rest of V, W20-
W64, W75-W99, 
X10-X39, X50-
X59, Y40-Y86, 
Y88, Y89
U155 (Rehm et al., 2004)
Self-infl icted injuries a X60-X84, Y870 U157 (Rehm et al., 2004)
Violence a X85-Y09, Y871 U158 (Rehm et al., 2004)
Other intentional injuries a Y35 U160 (Rehm et al., 2004)
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The aim of this project was to model the impact of alcohol 
on mortality, years of life lost and burden of disease for Swit-
zerland in a way that is compatible with current effort of the 
WHO in alcohol monitoring and surveillance.
Methods
Data and estimation procedure for exposure 
Exposure was based on the 2002 Swiss Health Survey (Bun-
desamt für Statistik 2004). This survey is the third telephone 
survey conducted by the Federal Offi ce of Statistics in inter-
vals of fi ve years. Data were collected by a random sample (n 
= 19,706) of persons aged 15 and over, living in Switzerland. 
The response rate was 64 % at the household level. Field work 
was carried out between January and December 2002. How-
ever, as surveys underestimate the true consumption (Midanik 
1982; Rehm 1998), results had to be adjusted (for a descrip-
tion of methodology see Rehm et al., in press). We used the 
adult per capita data from the WHO Global Alcohol Database 
(http://www.who.int/globalatlas/default.asp) as basis for this 
adjustment. According to this source, 13.2 l pure alcohol were 
consumed per capita in Switzerland in 2002 in the population 
15 years and older: 12.2 l recorded, 1 l unrecorded. Unrecord-
ed consumption in the WHO is estimated based on surveys, 
indirect estimation method or expert judgements (Rehm et al. 
2007). The survey data accounted for 48 % of the per capita 
consumption.
The estimates for this study are based on a combination of 
both data sources, where the adult per capita consumption is 
taken as the best indicator of the overall level of consumption 
(Gmel & Rehm 2004), and survey information is taken as the 
best indicator for the distribution of consumption by sex and 
age. The exact methods are described elsewhere (Rehm et al. 
2006a; Rehm et al. 2006b; 2007b).
Data indicating burden of disease
Mortality, years of life lost (YLLs) and disability-adjusted 
life-years (DALYs) were the main outcomes used in this anal-
ysis (see http://www.who.int/whosis/whostat2006YearsOf-
LifeLost.pdf). Mortality was measured by number of deaths, 
YLLs were calculated from the number of deaths multiplied 
by a standard residual life expectancy at the age at which death 
occurred (life expectancy at birth: 80 years for men and 82.5 
years for women), and the DALYs calculation added YLLs 
with years of life lost due to living with a disability. Overall 
estimates by disease category, sex and age for mortality, YLLs 
and DALYs for the year 2002 for Switzerland were obtained 
at WHO Headquarters (Dr. C. Mathers). YLLs and DALYs 
were 3 % age-discounted and age-weighted to be comparable 
with the Global Burden of Disease (GBD) study (Mathers et 
al. 2003; for a general defi nition of concepts see Lopez et al. 
(2006)). Population data were obtained from United Nations 
population division (United Nations 2005). Age groups used 
were: 0–4 years, 5–14 years, 15–29 years, 30–44 years, 45–59 
years, 60–69 years, and 70+ years. 
Relating alcohol exposure to disease and injury outcomes
Alcohol consumption was found to be causally related to 
a number of diseases, both chronic and acute, as well as a 
number of injury categories. The disease categories were 
taken from the GBD study (for GBD categories: Mathers et 
al. 2001; for the relationship to alcohol: Rehm et al. 2003c; 
Rehm et al. 2004) and are listed in Table 1. 
RR – relative risk
a AAFs are taken from CRA for non-A regions (based on pooled cross-sectional time-series analyses)
b  V01-V04, V06, V09-V80, V87, V89, V99. If four-digit ICD-10 data are available, use: V01.1-V01.9, V02.1-V02.9, V03.1-V03.9, V04.1-V04.9, V06.1-
V06.9, V09.2, V09.3, V10.4-V10.9, V11.4-V11.9, V12.3-V12.9, V13.3-V13.9, V14.3-V14.9, V15.4-V15.9, V16.4-V16.9, V17.4-V17.9, V18.4-V18.9, 
V19.4-V19.6, V20.3-V20.9, V21.3-V21.9, V22.3-V22.9, V23.3-V23.9, V24.3-V24.9, V25.3-V25.9, V26.3-V26.9, V27.3-V27.9, V28.3-V28.9, V29.4-V29.9, 
V30.4.V30.9, V31.4-V31.9, V32.4-V32.9, V33.4-V33.9, V34.4-V34.9, V35.4-V35.9, V36.4-V36.9, V37.4-V37.9, V38.4-V38.9, V39.4-V39.9, V40.4-V40.9, 
V41.4-V41.9, V42.4-V42.9, V43.4-V43.9, V44.4-V44.9, V45.4-V45.9, V46.4-V46.9, V47.4-V47.9, V48.4-V48.9, V49.4-V49.9, V50.4-V50.9, V51.4-V51.9, 
V52.4-V52.9, V53.4-V53.9, V54.4-V54.9, V55.4-V55.9, V56.4-V56.9, V57.4-V57.9, V58.4-V58.9, V59.4-V59.9, V60.4-V60.9, V61.4-V61.9, V62.4-V62.9, 
V63.4-V63.9, V64.4-V64.9, V65.4-V65.9, V66.4-V66.9, V67.4-V67.9, V68.4-V68.9, V69.4-V69.9, V70.4-V70.9, V71.4-V71.9, V72.4-V72.9, V73.4-V73.9, 
V74.4-V74.9, V75.4-V75.9, V76.4-V76.9, V77.4-V77.9, V78.4-V78.9, V79.4-V79.9, V80.3-V80.5, V81.1, V82.1, V83.0-V83.3, V84.0-V84.3, V85.0-V85.3, 
V86.0-V86.3, V87.0-V87.8, V89.2, V89.9, V99, Y850.
Drinking categories Men Women 
Abstainer or very light drinker 0–<0.25 g/day 0–<0.25 g/day
Drinking category I 0.25–<40 g/day 0.25–<20 g/day
Drinking category II 40–<60 g/day 20–<40 g/day
Drinking category III 60+ g/day 40+ g/day
a  The limits of these categories are stated in grams of pure alcohol per day. For reference, a bottle of table wine contains about 70 grams of 
ethanol; 0.25 g/day corresponds to somewhat less than one glass of wine per month.
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To determine the benefi cial and detrimental health conditions 
causally attributable to alcohol for inclusion in this study, the 
usual epidemiological criteria were used with specifi c empha-
sis on the following (Hill 1965; English et al. 1995; Rothman 
& Greenland 1998): consistency across several studies, estab-
lished experimental biological evidence of mediating proc-
esses or at least strong physiological plausibility (biological 
mechanisms), strength of the association (effect size), and 
temporality (i. e., cause before effect).
The disease categories found to be causally related were also 
cross-validated against major reviews (for a summary: Rehm 
et al. 2003c). The fi nal selection was the same as for the 
Comparative Risk Assessment study (CRA) 2000 (Rehm et 
al. 2004; WHO 2002) with one exception: colorectal cancer 
was added. In other words, all of the major review studies in 
the 1990s and the early 2000s concluded a causal relationship 
between alcohol and the respective disease or injury category 
selected for this study (Rehm et al. 2003c), except for color-
ectal cancer, where some of the evidence is newer (Boffetta et 
al. 2006; Cho et al. 2004). In 2007, the International Agency 
for Research on Cancer (Baan et al. 2007) established alcohol 
consumption to be carcinogenic for colorectal cancer, and thus 
the decision to include this type of cancer seems justifi ed.
The same criteria were used for determining causality with 
respect to detrimental and benefi cial effects. Care was taken 
to control for potential confounding, especially confounding 
by tobacco smoking. Thus, even though alcohol was consist-
ently related to lung cancer, even after usual control for con-
founding, it was not included as alcohol-attributable, because 
up to now there is no convincing biological pathway, and 
because residual confounding by tobacco smoking cannot be 
excluded.
Risk relations
Table 1 gives an overview on relative risks (RR) for different 
diseases by drinking categories.  For most chronic disease cat-
egories, alcohol-attributable fractions (AAFs) of disease were 
derived from combining the prevalence of exposure and rela-
tive risk estimates based on meta-analyses (Cho et al. 2004; 
Corrao et al. 2000; English et al. 1995; Gutjahr et al. 2001; 
Rehm et al. 2003c; Ridolfo & Stevenson 2001) using the fol-
lowing formula (Walter 1976; 1980):
                        k
             Σ Pi(RRi – 1)
                     i = 0AF = 
 
                  k
          Σ Pi(RRi – 1) + 1
                i = 0
Where
i:  exposure category with baseline exposure or no 
exposure i = 0
RR(i):  relative risk at exposure level i compared to no 
consumption
P(i): prevalence of the ith category of exposure
AAFs, as derived from the formula above, can be interpreted 
as refl ecting the proportion of disease that would disappear if 
there had been no alcohol consumption.
For depression and injuries, AAFs were taken from the CRA 
study (see Rehm et al. 2004, for a detailed description of un-
derlying assumptions and calculations). All AAFs by sex and 
age are available from the fi rst author upon request.
Results
Prevalence of exposure
Table 2 presents prevalence of alcohol consumption in Swit-
zerland in 2002 as estimated by the Swiss Health Survey 
(weighted to refl ect age- and sex-distribution of the Swiss 
population aged 15 and over) and adjusted for per capita con-
sumption. In total, 15.4 % of all adult men and 34.0 % of all 
women in Switzerland in 2002 were abstinent. 
Mortality
Deaths attributable to alcohol consumption in Switzerland 
and WHO sub region Europe A are shown in Table 3. Overall, 
2432 men and 1033 women died because of alcohol consump-
tion and, taking into consideration the benefi cial effects, 1575 
net deaths among men and 441 net deaths among women 
were attributed to alcohol consumption. In relative terms, al-
cohol consumption caused almost 4 times as many net deaths 
in men compared to women, respectively, which was expect-
ed given the higher consumption in men. Despite their dif-
ferences in relative and absolute mortality, however, the top 
causes of death were the same for both men and women, with 
the top three being cancer (M: 33.7 % of all alcohol-attribut-
able deaths, W: 39.5 %), cardiovascular diseases (M: 18.7 %, 
W: 17.7 %), and liver cirrhosis (M: 17.9 %, W: 18.4 %). In 
addition to causing death, alcohol also prevented death from 
cardiovascular diseases (mainly ischaemic heart disease) and 
diabetes mellitus. Cardiovascular mortality prevented totalled 
649 for men and 544 for women, which was greater than all 
deaths caused by alcohol-attributable cardiovascular diseases 
for each sex in Switzerland. Overall in Switzerland, alcohol 
prevented roughly one-third of all deaths caused by alcohol in 
men and about half of all deaths caused in women.
Comparison with the rest of Western Europe as operational-
ized by the WHO Europe A region showed some similarities 
and differences. Among deaths caused by alcohol, Switzer-
land and Europe A were identical in the top three categories, 
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although the relative importance of alcohol-attributable liver 
cirrhosis was higher in Europe A, and cardiovascular dis-
eases were relatively more important in Switzerland. Deaths 
prevented by alcohol, especially for cardiovascular diseases, 
showed some marked differences. In Europe A, the deaths 
prevented by alcohol totalled approximately half of all al-
cohol-attributable deaths for men and outnumbered deaths 
among women by a factor of 2, resulting in a net preventive 
effect of alcohol among women in Europe A. In Switzerland, 
however, there were approximately three times more deaths 
caused by alcohol than prevented among men, and twice as 
many among women, accounting for the opposite net effect 
seen in Swiss women compared to European women (1.4 % 
of all deaths versus –2.4 %) and the higher relative importance 
of alcohol as a cause of death in Swiss men compared to the 
rest of Europe A (5.2 % of all deaths versus 3.5 %).
Years of life lost
Alcohol-attributable YLLs in Switzerland and comparisons 
with the rest of Europe A are shown in Table 4. Among Swiss 
men and women, the top three causes of YLLs were cancer, 
liver cirrhosis, and unintentional injuries. The shift from car-
diovascular diseases to unintentional injuries was due to the 
fi nding that acute outcomes such as injury categories were 
associated with younger aged cohorts compared to chronic 
disease categories more associated with older age groups. 
Similar trends with respect to YLLs caused and prevented by 
alcohol were also seen within Switzerland and in comparison 
to Europe A, with much higher relative YLLs prevented in 
Europe A among both men and women. This was especially 
true among women, where a net protective effect was seen in 
Europe A (-1.2 %) and a marked net detrimental effect was 
estimated for Switzerland (4.9 %).
Disability adjusted life years 
DALYs attributable to alcohol consumption in Switzerland 
and Europe A are shown in Table 5. The most striking differ-
ence between DALYs and YLLs/deaths was the much higher 
relative importance of neuropsychiatric disorders with respect 
to DALYs, especially alcohol use disorders. In Switzerland 
(and Europe) this disease category accounted for roughly half 
of all alcohol-attributable DALYs among men (52.5 %) and 
women (42.1 %). This was due to the fact that alcohol use 
disorders are much less fatal and occur earlier in life than the 
more traditional chronic diseases such as heart disease and 
cancers. The fact that DALYs are a time-based measure be-
comes important here, i. e. the longer one lives with a dis-
ability, the higher the DALYs. In addition, alcohol use and 
other neuropsychiatric disorders are chronic relapsing dis-
eases with multiple episodes over a lifetime, resulting in high Ta
b
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disability over the life course (Leshner 1999; McLellan et al. 
2000). The majority of the other DALYs caused by alcohol in 
Switzerland and Europe A consisted of cancer, liver cirrhosis, 
and unintentional injuries. The protective effect of alcohol 
was also diminished using DALYs as an outcome measure 
compared to mortality, accounting for roughly an eighth of 
DALYs caused in men and a quarter of life years caused in 
women in Switzerland. The diminished effect on DALYs is 
trivial, as alcohol use disorders were the main contributor to 
DALYs and alcohol cannot have a protective effect on alcohol 
use disorders.
In Europe A, this diminished effect was also seen, especially 
among men, where a ratio of about 8:1 was estimated. Among 
women, DALYs caused by alcohol outnumbered DALYs pre-
vented by a ratio of about 4:3. Overall, the relative detrimen-
tal impact of alcohol was similar in Swiss and European men, 
but about 3 times greater in Swiss compared to European 
women.
Discussion
Overall, before we discuss the implications for prevention, 
we would like to point out some methodological caveats. 
First, for consistency purposes and lack of alternatives, we 
took the mortality, YLL and DALY data from the WHO da-
tabase. Switzerland has not yet conducted a detailed burden 
of disease study, so these should be seen as approximations 
that will be updated when the Swiss data become available. 
Second, the relative risks were derived from meta-analyses 
and are assumed to be consistent across countries, mainly 
because they refl ect biological mechanisms. This assumption 
is probably not problematic for Switzerland, as most studies 
included in the meta-analyses are from European or North 
American countries with similar genetic background and 
health care systems. However, the AAFs for injury may be 
more problematic, as the relationship between alcohol and in-
jury has been shown to be infl uenced by culture and society 
Table 3 Deaths attributable to alcohol consumption in Switzerland and WHO region Europe Aa in 2002
 Switzerland EUR A
no. % no. %
 M W M W M W M W
Maternal and perinatal conditions 
(low birth weight)
0 0 0.0 0.0 34 25 0.0 0.0
Cancer 818 408 33.7 39.5 36,809 22,793 29.2 41.7
Diabetes mellitus 0 0 0.0 0.0 0 0 0.0 0.0
Neuropsychiatric disorders 243 113 10.0 11.0 12,912 3,953 10.2 7.2
Cardiovascular diseases 454 183 18.7 17.7 12,243 5,164 9.7 9.4
Cirrhosis of the liver 436 191 17.9 18.4 31,850 13,012 25.2 23.8
Unintentional injuries 318 90 13.1 8.7 25,594 7,840 20.3 14.3
Intentional injuries 162 48 6.7 4.7 6,824 1,898 5.4 3.5
Total detrimental effects attributable 
to alcohol
2,432 1,033 100 100 126,267 54,685 100.0 100.0
Diabetes mellitus –207 –47 24.2 8.0 –3,290 –3,108 5.6 3.0
Cardiovascular diseases –649 –544 75.8 92.0 –55,205 –99,691 94.4 97.0
Total benefi cial effects attributable 
to alcohol
–856 –591 100 100 –58,495 –102,799 100.0 100.0
All alcohol-attributable deaths 1,575 441 100.0 100.0 67,772 –48,114 100.0 100.0
All deaths 30,345 30,574 1,950,201 1,969,721
Percentage of all deaths attributable 
to alcohol
5.2 % 1.4 % 3.5 % –2.4 %
a  The WHO region Europe A denotes the part of Europe with very low childhood and very low adult mortality. It comprises the following countries: 
Andorra, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, 
Monaco, Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, Sweden, Switzerland, and United Kingdom.
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to a large degree (Sethi et al. 2006). It is necessary that ongo-
ing and future Swiss studies should be used to put the results 
of this study in perspective. Third, the estimates for the age 
group 70 years and older are certainly overestimates, both for 
benefi cial and detrimental effects. Relative risks have been 
shown to decrease with age and, while there are quantifi ca-
tions of this effect for major tobacco-related risks, no quantifi -
cation exists for alcohol-attributable diseases (see Rehm et al. 
(2006c) for references and further information). Fourth, there 
may be some confounding by smoking which has not been 
removed by the usual techniques for control. For some aero-
digestive cancers particularly (such as laryngeal, pharyngeal), 
there are independent and joint effects of tobacco and alcohol 
(Taylor & Rehm 2006), so that a small percentage of these 
cancers may be overestimated in the current study based on 
those studies in the meta-analyses, which did not adequately 
control for these effects. Last, the procedure for adjustment 
of the survey data may overestimate consumption in heavy 
drinking categories if a key assumption for this procedure, 
i. e., that undercoverage is a result of missing certain heavy 
drinking populations such as the homeless and the institution-
alized, is not valid (Gmel & Rehm 2004). Rehm et al. (2006c) 
give some sensitivity analyses for potential consequences for 
burden of disease if certain assumptions for adjusting survey 
data do or do not hold true.
The fi nal point we would like to discuss concerns causality. 
As outlined above, we used the usual epidemiological cri-
teria of causality (Hill 1965; Rothman & Greenland 1998). 
In using these criteria, we stressed especially the potential 
biological pathways, and no disease condition was included 
without such a pathway. In past years, there has been doubt 
concerning the benefi cial effects of alcohol, especially the 
cardio-protective effect (Shaper 1990; Fillmore et al. 2006). 
Most of these claims have been made based on epidemio-
logical reasoning, i. e. lack of or inadequate control for con-
founders. While there is certainly room for improving the 
Table 4 YLLs attributable to alcohol consumption in Switzerland and WHO region Europe Aa in 2002
 Switzerland EUR A
no. % no. %
 M W M W M W M W
Maternal and perinatal conditions 
(low birth weight)
9 3 0.0 0.0 1,114 829 0.1 0.1
Cancer 7,938 4,333 27.4 36.8 406,401 258,511 22.2 37.9
Diabetes mellitus 0 0 0.0 0.0 0 0 0.0 0.0
Neuropsychiatric disorders 3,059 1,472 10.6 12.5 199,884 60,077 10.9 8.8
Cardiovascular diseases 3,488 1,465 12.0 12.4 119,588 42,103 6.5 6.2
Cirrhosis of the liver 5,246 2,393 18.1 20.3 427,765 173,927 23.4 25.5
Unintentional injuries 5,967 1,212 20.6 10.3 528,526 108,532 28.9 15.9
Intentional injuries 3,270 911 11.3 7.7 144,790 37,458 7.9 5.5
Total detrimental effects attributable 
to alcohol
28,978 11,789 100 100 1,828,068 681,438 100.0 100.0
Diabetes mellitus –1,694 –392 23.8 8.3 –37,538 –25,453 7.6 3.2
Cardiovascular diseases –5,412 –4,329 76.2 91.7 –454,566 –777,957 92.4 96.8
Total benefi cial effects attributable 
to alcohol
–7,106 –4,721 100 100 –492,104 –803,410 100.0 100.0
All alcohol-attributable YLLs 21,871 7,068 100.0 100.0 1,335,964 –121,972 100.0 100.0
All YLLs 207,539 144,394 14,133,339 9,830,315 
Percentage of all YLLs attributable 
to alcohol
10.5% 4.9%   9.5% –1.2%   
a see Table 3 for further explanations.
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quality of measurement in alcohol-epidemiological studies, 
particularly with respect to measurement of patterns of drink-
ing (Rehm 1998), these criticisms cannot address the basic 
question of whether there is a demonstrated biological path-
way for the alcohol effect that can explain the epidemiologi-
cal effects (Rehm 2007). For the cardio-protective effect due 
to regular light to moderate drinking, such pathways have 
been demonstrated (Puddey et al. 1999; Rehm et al. 2003d). 
In experimental studies, regular light to moderate alcohol 
consumption has been shown to increase HDL cholesterol 
and to have a positive effect on platelet aggregation (Rehm 
et al. 2003d). In addition, other potential pathways with less 
conclusive evidence have been demonstrated (Puddey et al. 
1999; Rehm et al. 2003d). This was the reason why ischae-
mic heart disease was included in the list of alcohol-attribut-
able disease categories. The exact quantifi cation of this effect 
is another matter and it may well be that the effect has been 
overestimated by the meta-analysis chosen (Corrao et al. 
2000) because some of the underlying studies failed to con-
trol for some of the confounders. In any case, as alcohol has 
been identifi ed as one of the major risk factors for burden of 
disease on a global level (Rehm et al. 2004), further research 
is underway, which will lead to better risk-relation estimates 
and, in turn, to better quantifi cation of alcohol-attributable 
burden of disease.
Despite these caveats, the estimates presented are the best 
possible for Switzerland for today and, for lack of better es-
timates, should infl uence policy. Thus, best practices to re-
duce per capita consumption (Babor et al. 2003; Anderson & 
Baumberg 2006) should apply to Switzerland, such as taxa-
tion and availability restrictions.
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Table 5 DALYs attributable to alcohol consumption in Switzerland and WHO region Europe Aa in 2002
 Switzerland EUR A
no. % no. %
 M W M W M W M W
Maternal and perinatal conditions 
(low birth weight)
19 10 0.0 0.0 1,755 1,419 0.0 0.1
Cancer 8,331 4,816 13.2 22.8 425,555 289,368 10.9 22.9
Diabetes mellitus 0 0 0.0 0.0 0 0 0.0 0.0
Neuropsychiatric disorders 33,271 8,886 52.8 42.1 2,008,786 509,204 51.2 40.3
Cardiovascular diseases 4,324 1,613 6.9 7.6 168,881 46,230 4.3 3.7
Cirrhosis of the liver 6,288 3,021 10.0 14.3 520,850 225,561 13.3 17.8
Unintentional injuries 7,420 1,791 11.8 8.5 643,717 152,646 16.4 12.1
Intentional injuries 3,416 976 5.4 4.6 151,130 39,953 3.9 3.2
Total detrimental effects attributable 
to alcohol
63,070 21,113 100 100 3,920,674 1,264,381 100.0 100.0
Diabetes mellitus –2,929 –591 33.8 11.2 –104,457 –45,281 17.8 4.9
Cardiovascular diseases –5,742 –4,666 66.2 88.8 –481,918 –875,145 82.2 95.1
Total benefi cial effects attributable to 
alcohol
–8,671 –5,257 100 100 –586,375 –920,426 100.0 100.0
All alcohol-attributable DALYs 54,399 15,856 100.0 100.0 3,334,299 343,955 100.0 100.0
All DALYs 420,560 378,056 27,329,000 24,395,683
Percentage of all DALYs attributable 
to alcohol
12.9% 4.2%   12.2% 1.4%   
a see Table 3 for further explanations. 
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Resumen
Consumo de alcohol y la enfermedad atribuible de alcohol en 
Suiza, 2002 
Objetivos: Este análisis estimó la carga de la enfermedad atri-
buible al alcohol en Suiza.
Métodos: Las distribuciones de la exposición fueron tomadas 
del estudio de Salud Suiza del 2002 y modifi cadas según la con-
sumición de alcohol por capita. Las relaciones de riesgo fueron 
tomadas por meta-análisis. Los datos de mortalidad y carga de 
la enfermedad fueron tomados de la Organización Mundial de 
la Salud.
Resultados: El consumo total, la mortalidad y la carga del al-
cohol-atribuibles a la enfermedad en Suiza resultaron ser altos 
comparados con los promedios globales europeos, especial-
mente entre mujeres. En toda Suiza en 2002, hubieron 2.016 
muertes (5.2 % de todas las muertes en hombres, 1.4 % en 
mujeres), 28.939 años de vida perdida (hombres: 10.5 %, mu-
jeres: 4.9 %) y 70.256 años de vida modifi cada por invalidez 
(hombres: 12.9 %, mujeres: 4.2 %) fueron atribuibles al alcohol. 
Estos números son números netos que incorporan ya efectos 
cardio-protectores y otros efectos benefi ciosos del alcohol. 
Conclusiones: Las limitaciones de la aproximación usada están 
siendo discutidas. Además, también se están tratando las cues-
tiones de la causalidad y la confusión.
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